nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.152	0.332	CbGbCtD
Fosamprenavir—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.142	0.308	CbGbCtD
Fosamprenavir—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.065	0.142	CbGbCtD
Fosamprenavir—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0596	0.13	CbGbCtD
Fosamprenavir—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0406	0.0885	CbGbCtD
Fosamprenavir—Amprenavir—ABCB1—peripheral nervous system neoplasm	0.00423	1	CrCbGaD
Fosamprenavir—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00129	0.0024	CcSEcCtD
Fosamprenavir—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00237	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.00126	0.00235	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.00126	0.00234	CcSEcCtD
Fosamprenavir—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.00125	0.00234	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Etoposide—peripheral nervous system neoplasm	0.00125	0.00233	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00233	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00233	CcSEcCtD
Fosamprenavir—Myocardial infarction—Etoposide—peripheral nervous system neoplasm	0.00125	0.00232	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00123	0.0023	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.00123	0.00229	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00228	CcSEcCtD
Fosamprenavir—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00227	CcSEcCtD
Fosamprenavir—Inflammation—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.00226	CcSEcCtD
Fosamprenavir—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.0012	0.00224	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00119	0.00222	CcSEcCtD
Fosamprenavir—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00119	0.00222	CcSEcCtD
Fosamprenavir—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00119	0.00222	CcSEcCtD
Fosamprenavir—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00119	0.00222	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00118	0.0022	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00118	0.0022	CcSEcCtD
Fosamprenavir—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00118	0.0022	CcSEcCtD
Fosamprenavir—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00118	0.0022	CcSEcCtD
Fosamprenavir—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00118	0.00219	CcSEcCtD
Fosamprenavir—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.00117	0.00218	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00117	0.00218	CcSEcCtD
Fosamprenavir—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00117	0.00217	CcSEcCtD
Fosamprenavir—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.00116	0.00215	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00113	0.0021	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.00113	0.0021	CcSEcCtD
Fosamprenavir—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00113	0.0021	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00112	0.00209	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00112	0.00209	CcSEcCtD
Fosamprenavir—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.00112	0.00208	CcSEcCtD
Fosamprenavir—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00109	0.00203	CcSEcCtD
Fosamprenavir—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00109	0.00203	CcSEcCtD
Fosamprenavir—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00202	CcSEcCtD
Fosamprenavir—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00202	CcSEcCtD
Fosamprenavir—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00202	CcSEcCtD
Fosamprenavir—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00202	CcSEcCtD
Fosamprenavir—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00202	CcSEcCtD
Fosamprenavir—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00202	CcSEcCtD
Fosamprenavir—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00108	0.00201	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.002	CcSEcCtD
Fosamprenavir—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00199	CcSEcCtD
Fosamprenavir—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.00199	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00198	CcSEcCtD
Fosamprenavir—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.00106	0.00197	CcSEcCtD
Fosamprenavir—Myalgia—Vincristine—peripheral nervous system neoplasm	0.00104	0.00195	CcSEcCtD
Fosamprenavir—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00103	0.00192	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00102	0.0019	CcSEcCtD
Fosamprenavir—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.0019	CcSEcCtD
Fosamprenavir—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00102	0.0019	CcSEcCtD
Fosamprenavir—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00101	0.00188	CcSEcCtD
Fosamprenavir—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00101	0.00188	CcSEcCtD
Fosamprenavir—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00188	CcSEcCtD
Fosamprenavir—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000997	0.00186	CcSEcCtD
Fosamprenavir—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000991	0.00185	CcSEcCtD
Fosamprenavir—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00099	0.00184	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.000984	0.00183	CcSEcCtD
Fosamprenavir—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000983	0.00183	CcSEcCtD
Fosamprenavir—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000983	0.00183	CcSEcCtD
Fosamprenavir—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000981	0.00183	CcSEcCtD
Fosamprenavir—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000977	0.00182	CcSEcCtD
Fosamprenavir—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000974	0.00181	CcSEcCtD
Fosamprenavir—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000971	0.00181	CcSEcCtD
Fosamprenavir—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00097	0.00181	CcSEcCtD
Fosamprenavir—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00097	0.00181	CcSEcCtD
Fosamprenavir—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000966	0.0018	CcSEcCtD
Fosamprenavir—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000957	0.00178	CcSEcCtD
Fosamprenavir—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000954	0.00178	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000946	0.00176	CcSEcCtD
Fosamprenavir—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000945	0.00176	CcSEcCtD
Fosamprenavir—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000938	0.00175	CcSEcCtD
Fosamprenavir—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000938	0.00175	CcSEcCtD
Fosamprenavir—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000926	0.00172	CcSEcCtD
Fosamprenavir—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000923	0.00172	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000917	0.00171	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000916	0.00171	CcSEcCtD
Fosamprenavir—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000914	0.0017	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000912	0.0017	CcSEcCtD
Fosamprenavir—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000906	0.00169	CcSEcCtD
Fosamprenavir—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000906	0.00169	CcSEcCtD
Fosamprenavir—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000903	0.00168	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000897	0.00167	CcSEcCtD
Fosamprenavir—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000895	0.00167	CcSEcCtD
Fosamprenavir—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000886	0.00165	CcSEcCtD
Fosamprenavir—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000886	0.00165	CcSEcCtD
Fosamprenavir—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000878	0.00164	CcSEcCtD
Fosamprenavir—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000871	0.00162	CcSEcCtD
Fosamprenavir—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000871	0.00162	CcSEcCtD
Fosamprenavir—Rash—Topotecan—peripheral nervous system neoplasm	0.000871	0.00162	CcSEcCtD
Fosamprenavir—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00087	0.00162	CcSEcCtD
Fosamprenavir—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00087	0.00162	CcSEcCtD
Fosamprenavir—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000868	0.00162	CcSEcCtD
Fosamprenavir—Headache—Topotecan—peripheral nervous system neoplasm	0.000865	0.00161	CcSEcCtD
Fosamprenavir—Rash—Tretinoin—peripheral nervous system neoplasm	0.000864	0.00161	CcSEcCtD
Fosamprenavir—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000864	0.00161	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000864	0.00161	CcSEcCtD
Fosamprenavir—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000863	0.00161	CcSEcCtD
Fosamprenavir—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000863	0.00161	CcSEcCtD
Fosamprenavir—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000863	0.00161	CcSEcCtD
Fosamprenavir—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00086	0.0016	CcSEcCtD
Fosamprenavir—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00086	0.0016	CcSEcCtD
Fosamprenavir—Headache—Tretinoin—peripheral nervous system neoplasm	0.000859	0.0016	CcSEcCtD
Fosamprenavir—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000859	0.0016	CcSEcCtD
Fosamprenavir—Rash—Melphalan—peripheral nervous system neoplasm	0.000853	0.00159	CcSEcCtD
Fosamprenavir—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000852	0.00159	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000849	0.00158	CcSEcCtD
Fosamprenavir—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000844	0.00157	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00084	0.00156	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000833	0.00155	CcSEcCtD
Fosamprenavir—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000825	0.00154	CcSEcCtD
Fosamprenavir—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000821	0.00153	CcSEcCtD
Fosamprenavir—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000821	0.00153	CcSEcCtD
Fosamprenavir—Nausea—Topotecan—peripheral nervous system neoplasm	0.000821	0.00153	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000818	0.00152	CcSEcCtD
Fosamprenavir—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000818	0.00152	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000816	0.00152	CcSEcCtD
Fosamprenavir—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000814	0.00152	CcSEcCtD
Fosamprenavir—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000814	0.00152	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000806	0.0015	CcSEcCtD
Fosamprenavir—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000804	0.0015	CcSEcCtD
Fosamprenavir—Nausea—Melphalan—peripheral nervous system neoplasm	0.000804	0.0015	CcSEcCtD
Fosamprenavir—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000791	0.00147	CcSEcCtD
Fosamprenavir—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000791	0.00147	CcSEcCtD
Fosamprenavir—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000787	0.00147	CcSEcCtD
Fosamprenavir—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000773	0.00144	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00077	0.00144	CcSEcCtD
Fosamprenavir—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000769	0.00143	CcSEcCtD
Fosamprenavir—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000766	0.00143	CcSEcCtD
Fosamprenavir—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000765	0.00143	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000764	0.00142	CcSEcCtD
Fosamprenavir—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000757	0.00141	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000755	0.00141	CcSEcCtD
Fosamprenavir—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000747	0.00139	CcSEcCtD
Fosamprenavir—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000745	0.00139	CcSEcCtD
Fosamprenavir—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000737	0.00137	CcSEcCtD
Fosamprenavir—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000735	0.00137	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000721	0.00134	CcSEcCtD
Fosamprenavir—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000718	0.00134	CcSEcCtD
Fosamprenavir—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000712	0.00133	CcSEcCtD
Fosamprenavir—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000711	0.00132	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000706	0.00132	CcSEcCtD
Fosamprenavir—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000706	0.00132	CcSEcCtD
Fosamprenavir—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000705	0.00131	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.0007	0.0013	CcSEcCtD
Fosamprenavir—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.0007	0.0013	CcSEcCtD
Fosamprenavir—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000699	0.0013	CcSEcCtD
Fosamprenavir—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000691	0.00129	CcSEcCtD
Fosamprenavir—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000687	0.00128	CcSEcCtD
Fosamprenavir—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000685	0.00128	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000667	0.00124	CcSEcCtD
Fosamprenavir—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000665	0.00124	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000663	0.00124	CcSEcCtD
Fosamprenavir—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000662	0.00123	CcSEcCtD
Fosamprenavir—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00066	0.00123	CcSEcCtD
Fosamprenavir—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000655	0.00122	CcSEcCtD
Fosamprenavir—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000654	0.00122	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000654	0.00122	CcSEcCtD
Fosamprenavir—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000652	0.00121	CcSEcCtD
Fosamprenavir—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000651	0.00121	CcSEcCtD
Fosamprenavir—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000643	0.0012	CcSEcCtD
Fosamprenavir—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000641	0.00119	CcSEcCtD
Fosamprenavir—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000641	0.00119	CcSEcCtD
Fosamprenavir—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00064	0.00119	CcSEcCtD
Fosamprenavir—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000636	0.00119	CcSEcCtD
Fosamprenavir—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000635	0.00118	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000632	0.00118	CcSEcCtD
Fosamprenavir—Rash—Vincristine—peripheral nervous system neoplasm	0.000631	0.00118	CcSEcCtD
Fosamprenavir—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00063	0.00117	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000629	0.00117	CcSEcCtD
Fosamprenavir—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000627	0.00117	CcSEcCtD
Fosamprenavir—Headache—Vincristine—peripheral nervous system neoplasm	0.000627	0.00117	CcSEcCtD
Fosamprenavir—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000617	0.00115	CcSEcCtD
Fosamprenavir—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000605	0.00113	CcSEcCtD
Fosamprenavir—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000605	0.00113	CcSEcCtD
Fosamprenavir—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000597	0.00111	CcSEcCtD
Fosamprenavir—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000595	0.00111	CcSEcCtD
Fosamprenavir—Nausea—Vincristine—peripheral nervous system neoplasm	0.000594	0.00111	CcSEcCtD
Fosamprenavir—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000594	0.00111	CcSEcCtD
Fosamprenavir—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000592	0.0011	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000585	0.00109	CcSEcCtD
Fosamprenavir—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000582	0.00108	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.00108	CcSEcCtD
Fosamprenavir—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.00058	0.00108	CcSEcCtD
Fosamprenavir—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000578	0.00108	CcSEcCtD
Fosamprenavir—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000574	0.00107	CcSEcCtD
Fosamprenavir—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000563	0.00105	CcSEcCtD
Fosamprenavir—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00056	0.00104	CcSEcCtD
Fosamprenavir—Rash—Cisplatin—peripheral nervous system neoplasm	0.000558	0.00104	CcSEcCtD
Fosamprenavir—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000557	0.00104	CcSEcCtD
Fosamprenavir—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000557	0.00104	CcSEcCtD
Fosamprenavir—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000555	0.00103	CcSEcCtD
Fosamprenavir—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.00102	CcSEcCtD
Fosamprenavir—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000549	0.00102	CcSEcCtD
Fosamprenavir—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000536	0.000999	CcSEcCtD
Fosamprenavir—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000535	0.000996	CcSEcCtD
Fosamprenavir—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000526	0.000979	CcSEcCtD
Fosamprenavir—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000515	0.00096	CcSEcCtD
Fosamprenavir—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000515	0.00096	CcSEcCtD
Fosamprenavir—Rash—Etoposide—peripheral nervous system neoplasm	0.000511	0.000952	CcSEcCtD
Fosamprenavir—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000511	0.000951	CcSEcCtD
Fosamprenavir—Headache—Etoposide—peripheral nervous system neoplasm	0.000508	0.000946	CcSEcCtD
Fosamprenavir—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000508	0.000946	CcSEcCtD
Fosamprenavir—Nausea—Etoposide—peripheral nervous system neoplasm	0.000482	0.000897	CcSEcCtD
Fosamprenavir—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000474	0.000883	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000471	0.000877	CcSEcCtD
Fosamprenavir—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000446	0.00083	CcSEcCtD
Fosamprenavir—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000441	0.000822	CcSEcCtD
Fosamprenavir—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.000817	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000812	CcSEcCtD
Fosamprenavir—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000807	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000771	CcSEcCtD
Fosamprenavir—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000768	CcSEcCtD
Fosamprenavir—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.000761	CcSEcCtD
Fosamprenavir—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000747	CcSEcCtD
Fosamprenavir—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000395	0.000736	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000731	CcSEcCtD
Fosamprenavir—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000392	0.00073	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000714	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000692	CcSEcCtD
Fosamprenavir—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000681	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000676	CcSEcCtD
Fosamprenavir—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000675	CcSEcCtD
Fosamprenavir—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000669	CcSEcCtD
Fosamprenavir—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000669	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000641	CcSEcCtD
Fosamprenavir—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000624	CcSEcCtD
Fosamprenavir—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000619	CcSEcCtD
Fosamprenavir—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000619	CcSEcCtD
Fosamprenavir—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000607	CcSEcCtD
Fosamprenavir—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000599	CcSEcCtD
Fosamprenavir—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000579	CcSEcCtD
Fosamprenavir—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000577	CcSEcCtD
Fosamprenavir—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000562	CcSEcCtD
Fosamprenavir—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000301	0.00056	CcSEcCtD
Fosamprenavir—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000554	CcSEcCtD
Fosamprenavir—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000538	CcSEcCtD
Fosamprenavir—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000536	CcSEcCtD
Fosamprenavir—Rash—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000534	CcSEcCtD
Fosamprenavir—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000533	CcSEcCtD
Fosamprenavir—Headache—Epirubicin—peripheral nervous system neoplasm	0.000285	0.00053	CcSEcCtD
Fosamprenavir—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000518	CcSEcCtD
Fosamprenavir—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000503	CcSEcCtD
Fosamprenavir—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000498	CcSEcCtD
Fosamprenavir—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000494	CcSEcCtD
Fosamprenavir—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000493	CcSEcCtD
Fosamprenavir—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000491	CcSEcCtD
Fosamprenavir—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000465	CcSEcCtD
